BioNano Genomics, Inc. (BNGO) Reports Q4 Net Loss of $29.5M

BioNano Genomics, Inc. (NASDAQ: BNGO) reported Q4 net loss of $29.5M. Revenue for the quarter came in at $6.3 million versus the consensus estimate of $5.57 million.

GUIDANCE:

BioNano Genomics, Inc. sees FY2022 revenue of $24-27 million.

For earnings history and earnings-related data on BioNano Genomics, Inc. (BNGO) click here.

You May Also Be Interested In

• Lucid reports Q2 output, names new CFO and five other leaders
• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
• Rivian raises 2026 delivery outlook after Q2 results top guidance